SENSEX NIFTY
YOU ARE HERE >  Moneycontrol Markets > Announcements Pharmaceuticals
Plethico Pharmaceuticals
BSE: 532739|NSE: PLETHICO|ISIN: INE491H01018|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Sep 17, 17:00
53.70
-2.8 (-4.96%)
VOLUME 38,210
LIVE
NSE
Sep 17, 17:00
53.30
-2.8 (-4.99%)
VOLUME 86,250
Announcements on Plethico Pharma

10th-Sep-2014 11:57Source: BSE

Plethico Pharma- Outcome of Board Meeting

Plethico Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on September 09, 2014, inter- alia, decided to postpone its 21st Annual General Meeting (AG...

9th-Sep-2014 20:09Source: NSE

Plethico Pharmaceuticals Limited

Plethico Pharmaceuticals Limited has informed the Exchange that the Board of Directors of the Company at their meeting held on September 09, 2014, inter-alia, decided to postpone its Annual General Me...

9th-Sep-2014 14:15Source: BSE

Plethico Pharma- Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992

Plethico Pharmaceuticals Ltd has submitted the disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992

8th-Sep-2014 15:53Source: BSE

Plethico Pharma- Disclosures under Reg.13(4A) of SEBI (Prohibition of Insider Trading) Regulations, 1992

Shashikant Patel has submitted the disclosure under Regulation 13(4A) of the SEBI (Prohibition of Insider Trading) Regulations, 1992 to BSE

8th-Sep-2014 15:45Source: BSE

Plethico Pharma- Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

Shashikant A Patel has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE

27th-Aug-2014 19:00Source: BSE

Plethico Pharma- Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992

Plethico Pharmaceuticals Ltd has submitted the disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992

27th-Aug-2014 15:10Source: BSE

Plethico Pharma- Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

Shashikant Patel has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE

27th-Aug-2014 15:04Source: BSE

Plethico Pharma- Disclosures under Reg.13(4A) of SEBI (Prohibition of Insider Trading) Regulations, 1992

Shashikant Patel has submitted the disclosure under Regulation 13(4A) of the SEBI (Prohibition of Insider Trading) Regulations, 1992 to BSE

13th-Aug-2014 23:33Source: BSE

Plethico Pharma- Outcome of Board Meeting (AGM on Sept 29, 2014)

Plethico Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on August 13, 2014, inter alia, has considered the following:

1. Fixing September 29...

5th-Aug-2014 14:17Source: BSE

Plethico Pharma- Closure of Trading Window

Plethico Pharmaceuticals Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on August 13, 2014, Inter alia, to consider, approve and take on record the Un-audite...

1 2 3 4 5 Next >>
Quick Links for Plethico Pharmaceuticals
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.